Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Bristol-Myers Squibb (NY: BMY )

53.90 -2.07 (-3.70%)
Official Closing Price Updated: 7:00 PM EST, Feb 14, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 13,227,293
Open 56.02
Bid (Size) 53.74 (1)
Ask (Size) 53.79 (4)
Prev. Close 55.97
Today's Range 53.66 - 56.02
52wk Range 39.35 - 61.10
Shares Outstanding 2,222,113,553
Dividend Yield 4.45%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
New Five-Year Sotyktu (deucravacitinib) Data Show Consistent Safety and Durable Response Rates in Moderate-to-Severe Plaque Psoriasis
From Bristol Myers Squibb
Via Business Wire
My “Two-Step” Plan for Surviving Shaky Markets – and Coming Out Ahead
Trump’s unpredictable tariff strategy is creating major market shifts. Discover how to read his next moves and uncover hidden investment opportunities before they take off. 
Via InvestorPlace
Topics Government World Trade
Exposures Political Tariff

Performance

YTD
-5.09%
-5.09%
1 Month
-4.40%
-4.40%
3 Month
-5.11%
-5.11%
6 Month
+9.33%
+9.33%
1 Year
+8.10%
+8.10%

More News

Read More
Bristol Myers Squibb Provides Update on Phase 3 RELATIVITY-098 Trial
From Bristol Myers Squibb
Via Business Wire
How to Read Trump’s Tariff Playbook – and Prepare for His Next Moves
Via InvestorPlace
Topics Government World Trade
Exposures Political Tariff
Earnings To Watch: Zoetis (ZTS) Reports Q4 Results Tomorrow
Via StockStory
Organon (OGN) Q4 Earnings Report Preview: What To Look For
Via StockStory
Gapping S&P500 stocks in Monday's session
Via Chartmill
What's Going On With Bristol Myers Squibb Stock On Monday?
Via Benzinga
Exposures Product Safety
Royalty Pharma Earnings: What To Look For From RPRX
Via StockStory
Bristol Myers Squibb Announces Positive Topline Results for Breyanzi® (lisocabtagene maraleucel) in Adult Patients with Relapsed or Refractory Marginal Zone Lymphoma
From Bristol Myers Squibb
Via Business Wire
MarketBeat Week in Review – 02/03 - 02/07
Via MarketBeat
Topics Artificial Intelligence Economy World Trade
Exposures Artificial Intelligence Interest Rates Tariff
Weak Guidance from Bristol-Myers Could Be Creating an Opportunity
Via MarketBeat
US Stocks Likely To Open On A Mixed Note: Amazon, Pinterest, Take-Two Among Stocks To Watch
Via Benzinga
S&P 500 Gains For 3rd Session: Investor Sentiment Improves, But Greed Index Remains In 'Fear' Zone
Via Benzinga
Topics Stocks
Exposures US Equities
Bristol Myers Squibb (BMY) Q4 2024 Earnings Call Transcript
Via The Motley Fool
Topics Earnings
Exposures Financial
Stocks Edge Higher, Bank Giants Rally, Palantir Skyrockets: What's Driving Markets Thursday?
Via Benzinga
Topics Stocks
Exposures US Equities
Dow Dips 150 Points; Bristol Myers Squibb Issues Weak Outlook
Via Benzinga
Topics Stocks
Exposures US Equities
Bristol Myers Squibb Tops Q4 Estimates
Via The Motley Fool
Bristol-Myers Squibb Stock Slides On Weak 2025 Outlook, Retail Steps In To Buy The Dip
Via Stocktwits
Wondering what's happening in today's S&P500 pre-market session?
Via Chartmill
Bristol Myers Squibb Warns Near-Term Impact Due To Generics On 2025 Sales Forecast, Outlines $2 Billion In Additional Cost Cuts
Via Benzinga
Bristol Myers Wallops Fourth-Quarter Earnings Views. But Shares Plummet 5%.
Via Investor's Business Daily
Bristol-Myers Squibb (NYSE:BMY) Posts Better-Than-Expected Sales In Q4 But Full-Year Sales Guidance Misses Expectations
Via StockStory
Bristol Myers Squibb Reports Fourth Quarter and Full-Year Financial Results for 2024
From Bristol Myers Squibb
Via Business Wire
US Stocks Likely To Open Higher Ahead Of Amazon's Earnings: 'Buy The Dip' Mentality Remains Prevalent, Says Analyst
Via Benzinga
Topics World Trade
Exposures Tariff
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.